{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:32Z","timestamp":1786119512572,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/wnf.0b013e3181f8d4ed","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T04:19:38Z","timestamp":1289621978000},"page":"303-311","source":"Crossref","is-referenced-by-count":20,"title":["Evidence for Use of Mood Stabilizers and Anticonvulsants in the Treatment of Nonaffective Disorders in Children and Adolescents"],"prefix":"10.1097","volume":"33","author":[{"given":"Alfred","family":"Amaladoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Amaladoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00004583-199607000-00012","article-title":"The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study.","volume":"35","author":"Shaffer","year":"1996","journal-title":"J Am Acad Child Adolescent Psychiatry"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0885-2006(00)00049-1","article-title":"Teachers judgement of problems in the transition to kindergarten.","volume":"15","author":"Rimm-Kaufman","year":"2000","journal-title":"Early Child Res Q"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1037\/0022-006X.66.5.715","article-title":"Preventing conduct problems in Head Start Children: strengthening parent competencies.","volume":"66","author":"Webster-Stratton","year":"1998","journal-title":"J Consult Clin Psychol"},{"key":"R5-8-20210203","first-page":"283","article-title":"Preventing conduct problems, promoting social competence: a parent and teaching partnership in Head Start.","volume":"30","author":"Webster-Stratton","year":"2001","journal-title":"J Consult Clin Psychol"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1176\/appi.ajp.2009.09020233","article-title":"Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.","volume":"166","author":"Blader","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archpsyc.58.4.389","article-title":"Parental and early childhood predictors of persistent physical aggression in boys from kindergarten to high school.","volume":"58","author":"Nagin","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/j.1440-1614.2005.01583.x","article-title":"Similarities and differences between aggressive and delinquent children and adolescents in a national sample.","volume":"39","author":"Rey","year":"2005","journal-title":"Aust N J Psychiatry"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/archpsyc.1987.01800210084013","article-title":"Ontario Child health study, II: six month prevalence of disorder and rates of service utilization.","volume":"44","author":"Offord","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00005053-198010000-00003","article-title":"Aggressive conduct disorder of children: the clinical picture.","volume":"168","author":"Stewart","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1037\/0022-006X.73.3.389","article-title":"Predicting future antisocial personality disorder in males from a clinical assessment in childhood.","volume":"73","author":"Lahey","year":"2005","journal-title":"J Consult Clin Psychol"},{"key":"R14-8-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00004583-199504000-00011","article-title":"Lithium in hospitalized aggressive children with conduct disorder: a double-blind placebo-controlled study.","volume":"5","author":"Campbell","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archpsyc.1972.01750280083014","article-title":"Lithium in emotionally unstable character disorder.","volume":"27","author":"Rifkin","year":"1972","journal-title":"Arch Gen Psychiatry"},{"key":"R16-8-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-440X(73)90022-9","article-title":"Long term use of lithium in aggressive prisoners.","volume":"14","author":"Tupin","year":"1973","journal-title":"Compr Psychiatry"},{"key":"R17-8-20210203","first-page":"445","article-title":"Divalproex sodium in the treatment of aggressive behavior.","volume":"5","author":"Wilcox","year":"1994","journal-title":"Ann Clin Psychiatry"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3949\/ccjm.56.8.756","article-title":"Anticonvulsants for treatment of manic depression.","volume":"56","author":"Deluchhi","year":"1989","journal-title":"Cleve Clin J Med"},{"key":"R19-8-20210203","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1528-1157.1999.tb00830.x","article-title":"A beneficial effect on mood in partial epilepsy patients treated with gabapentin.","volume":"40","author":"Harden","year":"1999","journal-title":"Epilepsia"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00213-006-0537-6","article-title":"Systematic review all pharmacotherapy of disruptive behavior disorders in children and adolescents.","volume":"191","author":"Ipser","year":"2007","journal-title":"Psychopharmacology"},{"key":"R21-8-20210203","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/10673220601082869","article-title":"Empirical evidence for the use of Lithium and anti-convulsants in children with psychiatric disorders.","volume":"14","author":"Lopez-Larson","year":"2006","journal-title":"Harv Rev Psychiatry"},{"key":"R23-8-20210203","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/cap.2008.076","article-title":"Trichotillomania: a case of response to valproic acid.","volume":"18","author":"Adewuya","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R24-8-20210203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1542\/peds.86.3.467","article-title":"Valproic acid for the treatment of children with mental retardation and mood symptomatology.","volume":"86","author":"Kastner","year":"1990","journal-title":"Pediatrics"},{"key":"R25-8-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archpsyc.1970.01750010082015","article-title":"Diphenylhydantoin in children with severe temper tantrums.","volume":"23","author":"Looker","year":"1970","journal-title":"Arch Gen Psychiatry"},{"key":"R26-8-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/088307389601100613","article-title":"Carbamazepine trial for Lesch-Nyan self mutilation.","volume":"11","author":"Roach","year":"1996","journal-title":"J Child Neurol"},{"key":"R27-8-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10578-006-0019-4","article-title":"Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder.","volume":"37","author":"Khanzode","year":"2006","journal-title":"Child Psychiatry Hum Dev"},{"key":"R28-8-20210203","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4088\/JCP.v64n1007","article-title":"Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.","volume":"64","author":"Steiner","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R29-8-20210203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S1461145705005791","article-title":"Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.","volume":"9","author":"Hollander","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"R30-8-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2005.08.006","article-title":"Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype.","volume":"88","author":"Barzman","year":"2005","journal-title":"J Affect Disord"},{"key":"R31-8-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.v58n0102","article-title":"Divalproex treatment of disruptive adolescence: report of 10 cases.","volume":"58","author":"Donovan","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R32-8-20210203","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1176\/appi.ajp.157.5.818","article-title":"Divalproex treatment for youth with explosive temper and mood lability: a double- blind, placebo-controlled crossover design.","volume":"157","author":"Donovan","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R33-8-20210203","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archpsyc.1984.01790180020002","article-title":"Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder.","volume":"41","author":"Campbell","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"R34-8-20210203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.57.7.649","article-title":"A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.","volume":"57","author":"Malone","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R35-8-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/0023210-200923010-00004","article-title":"Effectiveness of lithium in children and adolescents with conduct disorder.","volume":"23","author":"Masi","year":"2009","journal-title":"CNS Drugs"},{"key":"R36-8-20210203","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ajp.154.4.554","article-title":"Lithium treatment of conduct disorders in adolescents.","volume":"154","author":"Rifkin","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R37-8-20210203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/cap.2008.044","article-title":"Randomized double-blind placebo-controlled trial of lithium in youths with severe dysregulation.","volume":"19","author":"Dickstein","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R38-8-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004703-200208000-00006","article-title":"Levetiracetam in autistic children: an open-label study.","volume":"23","author":"Rugino","year":"2002","journal-title":"J Dev Behav Pediatr"},{"key":"R39-8-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.yic.0000224787.13782.0f","article-title":"Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.","volume":"21","author":"Wasserman","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R40-8-20210203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00004583-199604000-00014","article-title":"Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study.","volume":"35","author":"Cueva","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R41-8-20210203","first-page":"280","article-title":"Efficacy of topiramate in children and adolescents with problems in impulse control: preliminary studies.","volume":"34","author":"Dolengevich Segal","year":"2006","journal-title":"Actas Esp Psiquiatr"},{"key":"R42-8-20210203","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/appi.ajp.160.3.430","article-title":"Defining clinical phenotypes of juvenile mania.","volume":"160","author":"Leibenluft","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R43-8-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-1781(00)00248-1","article-title":"Diagnosis of manic episodes in adolescent in: structured diagnostic procedures compared to clinical chart diagnoses.","volume":"101","author":"Pogge","year":"2001","journal-title":"Psychiatry Res"},{"key":"R44-8-20210203","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1375\/twin.8.5.459","article-title":"Comorbidity between ADHD and symptoms of bipolar disorder in a community sample of children and adolescents.","volume":"8","author":"Reich","year":"2005","journal-title":"Twin Res Hum Genet"},{"key":"R45-8-20210203","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/npp.2009.202","article-title":"Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.","volume":"35","author":"Hollander","year":"2010","journal-title":"J Neuropsychopharmacol"},{"key":"R46-8-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biopsych.2008.04.030","article-title":"Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta -analysis.","volume":"64","author":"Amiet","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R49-8-20210203","first-page":"16","article-title":"Major system toxicities and side effects of anticonvulsants.","volume":"62","author":"Swann","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R50-8-20210203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0920-1211(90)90033-R","article-title":"Cognitive effects of valproate.","volume":"5","author":"Gallassi","year":"1990","journal-title":"Epilepsy Res"},{"key":"R52-8-20210203","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1528-1157.1999.tb01598.x","article-title":"Colitis may be part of the antiepileptic drug hypersensitivity syndrome.","volume":"40","author":"Eland","year":"1999","journal-title":"Epilepsia"},{"key":"R53-8-20210203","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1345\/aph.18054","article-title":"Severe multisystemic hypersensitivity reaction to carbamazepine including dyserythropoetic anemia.","volume":"33","author":"Lombardi","year":"1999","journal-title":"Ann Pharmacother"},{"key":"R54-8-20210203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/seiz.1999.0281","article-title":"Carbamazepine, hepatoxicity, organic solvents and paints.","volume":"8","author":"Kaufman","year":"1999","journal-title":"Seizure"},{"key":"R55-8-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1592\/phco.19.3.252.30918","article-title":"Suspected carbamazepine-induced hepatotoxicity.","volume":"19","author":"Morales-Diaz","year":"1999","journal-title":"Pharmacotherapy"},{"key":"R56-8-20210203","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(05)79759-2","article-title":"Topiramate and fulminant liver failure letter.","volume":"352","author":"Bjoro","year":"1998","journal-title":"Lancet"},{"key":"R57-8-20210203","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1528-1157.1994.tb02546.x","article-title":"Severe hepato-toxicity during valproate therapy: an update and report of eight new fatalities.","volume":"35","author":"Konig","year":"1994","journal-title":"Epilepsia"},{"key":"R58-8-20210203","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1528-1157.1999.tb00814.x","article-title":"Fatal liver failure associated with valproate therapy in a patient with Friedrich's disease: review of valproate hepatotoxicity in adults.","volume":"40","author":"Konig","year":"1999","journal-title":"Epilepsia"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181f8d4ed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:34Z","timestamp":1786041754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201011000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181f8d4ed","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}